Kevin McNamara has become Health Evolution Partners’ newest Operating Partner. Mr. McNamara will serve as Operating Partner with the firm’s Growth Buyout Fund and join the boards of portfolio companies CenseoHealth and Optimal Radiology.
Mr. McNamara has extensive experience in corporate operations, finance and investing in health services companies. He is a founding principal of McNamara Family Ventures, a family investment office providing venture and growth capital to health care companies, and currently serves on the boards of directors of Tyson Foods, Luminex Corporation, Leon Medical Centers, and Agilum Healthcare Intelligence. Mr. McNamara’s career includes leadership positions with HealthSpring (EVP and Chief Financial Officer), ProxyMed (Non-Executive Chairman and Interim Chief Executive Officer), Envoy (Chief Financial Officer and Director), and HCCA International (Chief Financial Officer). He received a BS in accounting from Virginia Commonwealth University and an MBA from the University of Richmond.
“We are excited to add Kevin to our team of accomplished health care professionals,” said David Brailer, MD, PhD, Managing Partner and Chief Executive Officer of Health Evolution Partners. “As Chief Financial Officer of HealthSpring, Kevin helped shepherd the company’s incredibly successful IPO and we look forward to bringing his expertise to help guide our portfolio of growth companies.”
Health Evolution Partners invests in companies that are commercial leaders in the health care industry. Sectors of interest include hospitals, physicians, managed care, pharmaceutical developers, device makers and consumer products and services. The firm is based in San Francisco (www.healthevolutionpartners.com).
“While I have spent my career leading large corporate enterprises, my passion lies with fast growing companies,” said Mr. McNamara. “Health Evolution Partners allows me to combine my experience with my passion, and provide valuable contributions to some of the most innovative health care companies operating today.”
© 2013 PEPD • Private Equity’s Leading News Magazine • 4-17-13